Skip to main content

Deal: Get the crazy dual-screen YotaPhone 2 for only $119.99

Image result for yotaphone dual screen
Looking to buy a phone on a low budget? Deals emerge often in the tech world, but this one is different for multiple reasons. The YotaPhone 2 was announced back in late 2014, so it definitely doesn’t compete with today’s favorites, but it is still a very special handset. And at only $119.99 it is quite a steal.
So what is it that makes the YotaPhone 2 a one-of-a-kind? Those of you who have been keeping track of the smartphone universe for long will remember the device’s quirky (yet helpful) dual-screen capabilities. One of them is a regular LCD panel, while the back of the phone touts an E-ink screen you can use for pretty much anything. The benefit of going black & white and sacrificing performance? Battery life!
You may notice the screen is usually what eats up most of your smartphone juice. E-ink needs very little energy, so using the secondary display should elongate battery life for days (literally). But you do need to get used to the black & white, as well as the slight delay.
In terms of specs, you are looking at a 5-inch 720p main display, a 4.7-inch 960×540 electronic paper display, a Qualcomm Snapdragon 801 processor, 2 GB of RAM, 32 GB of internal storage, an 8 MP main camera, a 2.1 MP front shooter and a 2,500 mAh battery.
Nothing to write home about as we approach the end of 2016, but it is still a pretty good phone… especially at only $119.99. Not to mention it is still one of the most interesting Android handsets the industry has seen. It will be fun playing around with and will guarantee great conversations, as well as looks.
Interested? Head over to GearBest.com, where you can buy the YotaPhone 2 for $119.99. It is listed for $135.99, but you can use coupon code “YOTAPGB” to bring the price down. By the way, this deal ends in 4 days and there are only a bit over 200 units left, so act quickly!
Who is getting one?
BUY THE YOTAPHONE 2 FROM GEARBEST.COM

Comments

Popular posts from this blog

The Secret Science 02:The 30 Most Disturbing Human Experiments in History

Disturbing human experiments aren’t something the average person thinks too much about. Rather, the progress achieved in the last 150 years of human history is an accomplishment we’re reminded of almost daily. Achievements made in fields like biomedicine and psychology mean that we no longer need to worry about things like deadly diseases or masturbation as a form of insanity. For better or worse, we have developed more effective ways to gather information, treat skin abnormalities, and even kill each other. But what we are not constantly reminded of are the human lives that have been damaged or lost in the name of this progress. The following is a list of the 30 most disturbing human experiments in history. 30. The Tearoom Sex Study Sociologist Laud Humphreys often wondered about the men who commit impersonal sexual acts with one another in public restrooms. He wondered why “tearoom sex” — fellatio in public restrooms — led to the majority of homosexual arrests in ...

The Strange and Stranger Case of Wyndham Lathem

A Northwestern University plague researcher has been charged with a brutal murder. Here’s what we know about him. WIKIMEDIA,  TONY WEBSTER O n July 27,  The  Chicago Tribune   reported that there was an arrest warrant issued for  Wyndham Lathem , a microbiologist at Northwestern University. The crime Lathem would later be charged with was brutal—26-year-old Trenton James Cornell-Duranleau, whose body was found in Lathem’s apartment, had been stabbed dozens of times. But Lathem was nowhere to be found. As events unfolded over the following days, it became clear he had fled from Chicago to California with a second suspect, 56-year-old Andrew Warren, a University of Oxford employee from the United Kingdom visiting the states. Along the way, the two men apparently made an anonymous $1,000 donation in Cornell-Duranleau’s name to the Lake Geneva Public Library and another donation for $5,610 to a Chicago health center. Lathem had also sent a video to fa...

Popular painkiller doesn’t have more heart risks than others, study claims

NEW ORLEANS — A long-awaited study on painkillers called nonsteroidal anti-inflammatory drugs, the most widely prescribed class of drugs in the world, has concluded that the three most commonly used carry a similar risk of cardiovascular complications. Yet critics say the study was too flawed to fairly compare them. Concerns about a type of NSAID called COX-2 inhibitors peaked in 2004 when the drug Vioxx was withdrawn from the market — a decision steeped in scandal because manufacturer Merck & Co had initially hidden data that would reveal the drug’s cardiovascular risks. A second COX-2 inhibitor, Pfizer Inc.’s Celebrex, was allowed to remain on the market with the condition that Pfizer conduct a study to prove that Celebrex was no worse than two older NSAIDs, naproxen and ibuprofen. The study lasted 10 years and enrolled more than 24,000 patients, but faced challenges. Doctors in European Union countries would not participate because they were worried a...